Warning: Undefined variable $count in /home/seniorca/public_html/wp-content/themes/divi-news-child-healthcare/index.php on line 40
Warning: Undefined variable $count in /home/seniorca/public_html/wp-content/themes/divi-news-child-healthcare/index.php on line 121
Akumin Files for Bankruptcy to Eliminate $470 Million in Debt
Radiology provider Akumin announced that it has filed for Chapter 11 bankruptcy protection in a bid to eliminate a debt of $470 million, as reported by Radiology Business. Akumin’s approach is to convert this debt into common shares of the company’s stock, which will be owned by their lender, Stonepeak. As part of this restructuring, Akumin will transition from a publicly traded entity to a privately held company, bolstered by an infusion of $130 million in new investment from Stonepeak. The decision marks the conclusion of a period of financial turmoil for Akumin, which saw the value of its stock plummet by more than 80% in the past year. This crisis was exacerbated by... Read More »
TriSpan Acquires SmartArches
TriSpan announced its acquisition of SmartArches from ProSmile, a multi-specialty dental organization in New Jersey, Pennsylvania and Maryland. Founded in December 2022, SmartArches is a specialty implant-focused dental company with a network of oral surgeons, implant and restorative dentists. It serves patients in eight locations throughout the United States. With offices in New York and London, TriSpan is a private equity firm that invests in lower middle market companies in North America, Europe and the United Kingdom with annual revenues ranging from $20-100 million. It was founded in 2015. According to data captured in the LevinPro HC database, this transaction... Read More »
MITRO Biotech Merges With XINGIMAGING
MITRO Biotech Co., Ltd and XingImaging, LLC announced a definitive agreement to merge. According to data captured in the LevinPro HC database, this transaction marks the 34th contract research organization (CRO) transaction of the year. XingImaging is a clinical PET imaging service and CRO that specializes in radiotracer production through positron emission tomography acquisition to evaluate. The CRO supports the development of treatments for neurodegenerative disorders such as Alzheimer and Parkinson disease, oncology and other disease pathologies. It has a location in Madison, Connecticut. MITRO Biotech is a molecular imaging CRO company based in Nanjing, China. The... Read More »
MEDICE Health Family Acquires femfeel
On October 14, MEDICE Health Family announced its acquisition of the telehealth app, femfeel. Based in Munich, Germany, femfeel is a digital platform designed to support patients through menopause. It offers a comprehensive suite of resources, that includes education about menopause, a symptom tracker and evaluation tool. It also connects patients to medical professionals. MEDICE Health Family is a pharmaceutical manufacturing company based in Iserlohn, Germany. Through various portfolio companies, its products provide care for ADHD in adults, anemia, bladder disfunction, insomnia and nephrology. medigital serves as MEDICE’s digital health competency center. This... Read More »
Pearl Street Dental Partners Expands Deeper into Texas
Pearl Street Dental Partners, backed by private equity firm SkyKnight Capital, announced on October 24 that it acquired two dental practices in Texas. Brush Dentistry operates in Saginaw, Texas and Derby Dental is based in Austin, Texas. Each practice has two physicians on staff. Pearl Street Dental Partners is a private dental services organization that is based in Dallas, Texas. Pearl Street Dental operates more than 35 practices across Texas and Oklahoma. Its network includes more than 80 dentists and 500 team members. This is Pearl Street Dental’s first acquisition of the year, as well as its first since it was bought by SkyNight Capital in 2022. The... Read More »
Physical Therapy Central Expands Oklahoma Footprint with FirstCare Rehabilitation
Physical Therapy Central (PTC) has announced its acquisition of FirstCare Rehabilitation, a physical therapy practice in Clinton, Oklahoma. FirstCare Rehabilitation has been providing comprehensive spine care, general orthopedics and neurological rehabilitation to patients since its inception in 1996. The company’s services address either the acute or chronic stage of injury and continue throughout the recovery and repair phases of healing. PTC, a member of the Confluent Health family, is an Oklahoma-based, private physical therapy practice group. Patients of the newly acquired practice will continue to receive the same quality of care, delivered by their familiar... Read More »
Montecito Medical Acquires Women’s Health MOB in Woodbury, Minnesota
Montecito Medical announced on October 23 the acquisition of a 32,711-square-foot medical office building (MOB) in Woodbury, Minnesota. The building is home to Minnesota Women’s Care, a leading specialty group serving patients throughout the Twin Cities area and western Wisconsin. The women’s health group maintains four office locations across its service area. Montecito Medical Real Estate specializes in healthcare-related real estate acquisitions and funding. Since 2006, it has completed transactions across the United States involving more than $5.1 billion in medical real estate. Through this MOB acquisition, Montecito expands its presence in Minnesota and the Upper... Read More »
PE-Backed Uniguest Announces Acquisition of pCare
Uniguest, a portfolio company of private equity firm Atlantic Street Capital, has announced the acquisition of pCare, expanding its presence and capabilities in healthcare. pCare is a New York-based provider of interactive patient engagement systems designed to improve patient outcomes and experience while making the work of healthcare teams safer and simpler. Uniguest is a global leader in digital engagement technology to multiple end markets. The company enables those in hospitality, senior living, sports/stadiums, entertainment, retail, education, government, healthcare, corporate and enterprise to engage with their audience. Uniguest’s Chief Executive Officer Matt... Read More »
Roche Acquires Telavant for $7.1 Billion
Roche Holding AG announced on October 23 that it will acquire Telavant Holdings from its majority owner, Roivant Sciences. Under the terms of the agreement, Roche will pay a purchase price of $7.1 billion upfront and a near-term milestone payment of $150 million. Telavant is a biotechnology company that produces drugs to treat inflammatory and fibrotic diseases. It is in the process of developing a new therapy for patients with Crohn’s disease. Telavant was jointly formed by Roivant and Pfizer, Inc. in 2022 to develop and commercialize RVT-3101, a monthly subcutaneously administered anti-TL1A antibody, in the United States and Japan. Roivant currently owns 75% of the issued and... Read More »Schedule a demo
Gain access to the best healthcare and long-term care investment intelligence, data, and analysis.
